Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice.
Fiche du document
2015
- doi: 10.1016/j.bone.2015.05.016
- issn: 1873-2763
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.bone.2015.05.016
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/25988660
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1873-2763
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_BCDB78CE284B5
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Therapy Risk evaluation Assessment, Risk Risk analysis Analysis, Risk Vertebrae, Lumbar Lumbar spine Probability Statistical inference Assessment Type 1 diabetes Brittle diabetes IDDM (Disease) Ketosis prone diabetes Diabetes mellitus Insulin-dependent diabetes Older persons Older adults Seniors (Older people) Elderly people Old people Senior citizens Aging people AgedCiter ce document
N.C. Harvey et al., « Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. », Serveur académique Lausannois, ID : 10.1016/j.bone.2015.05.016
Métriques
Partage / Export
Résumé
Trabecular bone score (TBS) is a recently-developed analytical tool that performs novel grey-level texture measurements on lumbar spine dual X-ray absorptiometry (DXA) images, and thereby captures information relating to trabecular microarchitecture. In order for TBS to usefully add to bone mineral density (BMD) and clinical risk factors in osteoporosis risk stratification, it must be independently associated with fracture risk, readily obtainable, and ideally, present a risk which is amenable to osteoporosis treatment. This paper summarizes a review of the scientific literature performed by a Working Group of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. Low TBS is consistently associated with an increase in both prevalent and incident fractures that is partly independent of both clinical risk factors and areal BMD (aBMD) at the lumbar spine and proximal femur. More recently, TBS has been shown to have predictive value for fracture independent of fracture probabilities using the FRAX® algorithm. Although TBS changes with osteoporosis treatment, the magnitude is less than that of aBMD of the spine, and it is not clear how change in TBS relates to fracture risk reduction. TBS may also have a role in the assessment of fracture risk in some causes of secondary osteoporosis (e.g., diabetes, hyperparathyroidism and glucocorticoid-induced osteoporosis). In conclusion, there is a role for TBS in fracture risk assessment in combination with both aBMD and FRAX.